Chapter 2: Enzymes

An enzyme is a biological catalyst - a protein (or in rare cases an RNA) that speeds up a chemical reaction without being consumed. The rate increase is enormous. A typical enzyme accelerates its reaction by $10^{6}$ to $10^{17}$ fold. Without enzymes, digesting a sandwich would take years.

Crucially, enzymes do not change whether a reaction can happen. A reaction with positive Gibbs free energy (ΔG > 0) stays non-spontaneous whether or not an enzyme is present. Enzymes only change how quickly an already-possible reaction reaches equilibrium.

Lowering Activation Energy

Every reaction has to climb an energy hill called the activation energy (Ea) before it can proceed. Substrates must twist, bend, or partially break bonds into a strained intermediate called the transition state before new bonds can form. Enzymes stabilize that transition state. A lower energy hill means more molecules have enough energy to make it over at body temperature, so the reaction runs faster.

The Active Site

The active site is a small pocket or cleft on the enzyme, usually only a few amino acids wide, where the substrate binds and catalysis happens. Two types of residues matter there:

• Binding residues grip the substrate through hydrogen bonds, van der Waals forces, hydrophobic packing, and sometimes ionic interactions. They set the specificity.
• Catalytic residues actually participate in the bond-making or bond-breaking. Common offenders are Ser, His, Asp, Cys, Lys, and Tyr - amino acids with reactive side chains.

The active site is a tiny fraction of the whole protein. Most of the enzyme is scaffolding that holds those critical residues in exactly the right 3D positions.

Substrate Specificity

Enzymes are dramatically more specific than non-biological catalysts. Hexokinase phosphorylates glucose but ignores nearly identical sugars like galactose. Specificity comes from the shape, charge, and hydrophobicity of the active site matching only a narrow set of substrates.

Some enzymes are absolutely specific (only one substrate, e.g., urease acts only on urea). Others have group specificity (any sugar with a free -OH, or any peptide bond adjacent to a lysine). Most fall somewhere in between.

Catalytic Mechanisms

Enzymes lower activation energy through a handful of recurring tricks. The MCAT expects you to recognize the four main mechanisms:

• Acid-base catalysis: an active-site residue donates or accepts a proton at a key step (histidine’s pKa near 6 makes it the star).
• Covalent catalysis: a nucleophilic residue (often serine, cysteine, or lysine) transiently forms a covalent bond with the substrate, creating a reactive intermediate. Serine proteases (chymotrypsin, trypsin) build an acyl-enzyme intermediate through Ser-OH.
• Metal-ion catalysis: a metal cofactor (Zn2+, Fe2+/Fe3+, Mg2+) polarizes substrates, stabilizes negative charges, or performs redox. Carbonic anhydrase uses Zn2+; cytochromes use iron.
• Electrostatic catalysis: charged residues in the active site stabilize oppositely charged transition-state intermediates (the “oxyanion hole” in serine proteases is the classic example).

The Catalytic Triad

The textbook case is the Ser-His-Asp triad of chymotrypsin. Asp polarizes His; His deprotonates Ser; Ser attacks the peptide bond’s carbonyl carbon. All three mechanisms appear simultaneously: acid-base (His shuttles protons), covalent (Ser forms acyl-enzyme), and electrostatic (Asp and the oxyanion hole stabilize charged intermediates).

Cofactors and Coenzymes

Many enzymes need a non-protein partner to function:

The B Vitamin Cofactor Map

The MCAT loves “vitamin → coenzyme → reaction → deficiency disease” chains. Memorize the vitamin-to-coenzyme link; the rest is context.

Biologists have used two models to describe how a substrate fits into an active site. The MCAT expects you to know both, to know which is modern and correct, and to know why the distinction matters.

Lock-and-Key Model (Emil Fischer, 1894)

In the lock-and-key model, the active site has a fixed, rigid shape. Only a substrate with the exact complementary shape can fit - like a key fitting a particular lock. Binding does not change either partner; the shapes are pre-formed.

This model correctly predicts enzyme specificity but is too simple. It implies the enzyme is a static sculpture, which it is not.

Induced Fit Model (Daniel Koshland, 1958)

In induced fit, the active site is flexible. When the substrate begins to bind, the enzyme changes shape to wrap around the substrate more snugly. The substrate may also deform slightly. The resulting “mutual adjustment” creates the catalytically active arrangement of residues that was not quite right in the empty enzyme.

Induced fit is the modern, correct model for most enzymes. It explains why enzymes are so good at stabilizing the transition state - the post-binding conformation is complementary to the transition state, not the ground-state substrate.

Hexokinase - The Classic Example

Hexokinase is the first enzyme of glycolysis. It transfers a phosphate from ATP onto glucose. When only the enzyme is present, the two lobes of hexokinase are open. When glucose binds, the lobes clamp down like a Venus flytrap, surrounding the sugar and excluding water.

Why the drama? Water would ruin everything. If water got into the active site, the ATP phosphate would be transferred onto water instead of glucose (ATP hydrolysis, a wasted reaction). By slamming shut on glucose, hexokinase guarantees that only glucose - not water - gets phosphorylated.

The International Union of Biochemistry and Molecular Biology sorts every enzyme into one of six classes based on the reaction it catalyzes. The MCAT will not ask for EC numbers, but you absolutely must recognize the six classes and what each one does.

The Six Classes

How to Tell Which Class from the Name

Enzyme names are often transparent once you know the suffix rules.

• -dehydrogenase removes H atoms (electrons + protons). Oxidoreductase. Example: alcohol dehydrogenase, lactate dehydrogenase.
• -kinase transfers a phosphate (usually from ATP). Transferase. Example: hexokinase, protein kinase A.
• -ase on a substrate name (lipase = breaks lipids, lactase = breaks lactose) is usually a hydrolase. It adds water across a bond.
• -decarboxylase removes CO2 without adding water. Lyase. Example: pyruvate decarboxylase.
• -synthase (no ATP) is a lyase. -synthetase (uses ATP) is a ligase. This one trips students up - the single extra letter changes the class.
• -isomerase or -mutase rearranges atoms. Isomerase. Example: triose phosphate isomerase, phosphoglycerate mutase.
• -ligase or -carboxylase (with ATP) joins things. Ligase. Example: pyruvate carboxylase, DNA ligase.

One-Sentence Examples per Class

• Oxidoreductase: lactate dehydrogenase moves H (and electrons) between lactate and pyruvate, paired with NAD+/NADH.
• Transferase: hexokinase transfers a phosphate from ATP onto glucose, producing glucose-6-phosphate.
• Hydrolase: trypsin adds water across a peptide bond, cleaving a protein into fragments.
• Lyase: fructose-1,6-bisphosphate aldolase cleaves a six-carbon sugar into two three-carbon pieces without water.
• Isomerase: triose phosphate isomerase interconverts dihydroxyacetone phosphate and glyceraldehyde-3-phosphate.
• Ligase: DNA ligase seals a nick in the DNA backbone, using ATP to drive the joining.

Enzyme kinetics is the study of how fast enzymes work and how that speed changes when you vary conditions. The core equation is Michaelis-Menten, published by Leonor Michaelis and Maud Menten in 1913. Every MCAT kinetics question ultimately comes back to it.

The Scenario

Mix one substrate (S) with an enzyme (E). The enzyme grabs the substrate to form an enzyme-substrate complex (ES), does its chemistry, then releases the product (P) and returns free.

E + S ⇌ ES → E + P

If you keep adding substrate and measure how fast product appears, you get the classic Michaelis-Menten curve.

Three features jump out:

1. At low [S], the curve is nearly linear. Doubling substrate doubles the rate.
2. At high [S], the curve flattens. Enzyme is saturated - nearly every molecule is already working on a substrate. Adding more does not help.
3. The asymptote is called Vmax. The substrate concentration at half-Vmax is called Km.

The Equation

$V_0 = \frac{V_{max}[S]}{K_m + [S]}$

• V0 = initial velocity (rate of product formation at t near zero, before product builds up enough to matter)
• Vmax = maximum rate achievable, when enzyme is fully saturated
• Km = Michaelis constant, the [S] at which V0 = Vmax / 2
• [S] = substrate concentration

What Km Actually Means

Km has two equivalent interpretations:

1. The substrate concentration that gives half the maximum reaction rate.
2. A rough measure of the affinity of the enzyme for the substrate. A small Km means high affinity (the enzyme is satisfied at low [S]). A large Km means low affinity (the enzyme needs a lot of substrate before it hits half-Vmax).

Assumptions of Michaelis-Menten

The derivation relies on a few assumptions that matter for the MCAT:

• Steady state: the concentration of ES is approximately constant while you measure. Formation and breakdown of ES are balanced.
• [S] >> [E]: you add much more substrate than enzyme, so free [S] is not measurably depleted by forming ES.
• V0 is measured before the reverse reaction matters. Product concentration is near zero, so P → S is negligible.
• One substrate, one active site. Simple Michaelis-Menten kinetics do not apply directly to allosteric enzymes with multiple binding sites (those give sigmoidal curves - covered later).

Km and Vmax are the two parameters you will be asked to read from kinetics plots and interpret in passages. They carry different information, and the MCAT will test whether you can tell them apart.

Vmax is About Enzyme Amount

Vmax is the ceiling - the maximum velocity the enzyme can achieve when substrate is so abundant that every active site is occupied at all times. Double the amount of enzyme and Vmax doubles. Half the enzyme and Vmax is halved. Vmax is proportional to [E]total.

Vmax is also set by how fast one enzyme molecule can turn over substrates - the turnover number kcat.

$V_{max} = k_{cat} \times [E]_{total}$

• kcat = number of substrate molecules converted per active site per second, at saturation
• [E]total = total enzyme concentration

Km is About Affinity, Not Amount

Km depends only on the identity of the enzyme and the substrate. It does NOT change when you add more enzyme. A passage that says “doubling [E] increased both Km and Vmax” is wrong - only Vmax responds to enzyme concentration.

Km changes only when:

• You change the enzyme (mutation, isoform).
• You change the substrate.
• You add something that changes the effective affinity, like a competitive inhibitor (which raises apparent Km) or a noncompetitive inhibitor (which does not).

Reading the Curve

To estimate Vmax by eye, look for where the curve flattens - that horizontal asymptote is Vmax. Drop down to half that value, then read left to the x-axis - that substrate concentration is Km.

Hexokinase vs. Glucokinase - A Classic Comparison

| Property | Hexokinase (muscle) | Glucokinase (liver) |
|----------|---------------------|---------------------|
| Km for glucose | ~0.1 mM (low, high affinity) | ~10 mM (high, low affinity) |
| Works at | Any blood glucose level | Only after a meal (high glucose) |
| Feedback | Inhibited by glucose-6-P (product) | Not inhibited by glucose-6-P |
| Role | Ensures muscle always has fuel | Buffers blood glucose, stores it |

kcat and the Specificity Constant

• kcat / Km is called the specificity constant. It measures how well an enzyme distinguishes between two competing substrates.
• A catalytically perfect enzyme has kcat/Km near $10^{8}$ M-1 s-1, meaning the rate is limited only by how fast substrate and enzyme can bump into each other (diffusion limit).

You do not need to calculate kcat/Km on the MCAT, but you should recognize that a bigger kcat/Km means the enzyme strongly prefers that substrate.

Hyperbolas are annoying to analyze. Straight lines are easy. The Lineweaver-Burk plot linearizes the Michaelis-Menten equation by taking the reciprocal of both sides, which makes it easy to read Km and Vmax off a graph and diagnose inhibitor types at a glance.

The Linearization

Start with Michaelis-Menten.

$V_0 = \frac{V_{max}[S]}{K_m + [S]}$

Flip both sides.

$\frac{1}{V_0} = \frac{K_m + [S]}{V_{max}[S]} = \frac{K_m}{V_{max}} \cdot \frac{1}{[S]} + \frac{1}{V_{max}}$

That is the equation of a line when 1/V0 is plotted against 1/[S].

What to Read Off the Plot

Why the Plot Matters for Inhibitors

The real power of Lineweaver-Burk is distinguishing inhibitor types by how the lines shift.

We will unpack each of these in the next three sections. For now, memorize what to look for on the plot.

Common Trap: Direction of Change

A “higher” y-intercept on Lineweaver-Burk means a LOWER Vmax (because the y-intercept is 1/Vmax). A “more positive” x-intercept - closer to zero or right of it - means a HIGHER Km. Students constantly flip this sign. Practice with a dozen plots until it is automatic.

Worked Example: Reading Km and Vmax from a Plot

A passage hands you a Lineweaver-Burk plot with a y-intercept at 0.02 (min/µM) and an x-intercept at -0.1 (1/µM). Find Km and Vmax.

A competitive inhibitor looks enough like the real substrate to bind the active site, but it cannot be catalyzed. When the inhibitor is sitting in the active site, the enzyme cannot do its job. When a real substrate arrives, it has to wait its turn - or, if there is a lot of substrate, it just outcompetes the inhibitor.

That word “outcompete” is the entire concept. Competitive inhibition can be reversed by adding more substrate. This is why Vmax does not change: with enough substrate, the enzyme still hits its full speed. Only the apparent Km goes up - it takes more substrate to reach half-Vmax because some of the substrate is being wasted fighting the inhibitor for active sites.

Effect on Km and Vmax

| Parameter | Change | Why |
|-----------|--------|-----|
| Km (apparent) | Increases | You need more substrate to reach half-Vmax because some substrate is wasted displacing inhibitor |
| Vmax | Unchanged | At infinite [S], substrate always wins; the enzyme still reaches its full speed |
| Binding site | Active site only | Inhibitor binds where substrate does |

Lineweaver-Burk Signature

On Lineweaver-Burk, competitive inhibition produces lines that all cross at the y-intercept. The y-intercept (1/Vmax) is fixed because Vmax is unchanged. The x-intercept (-1/Km) moves rightward (closer to zero), showing that Km has increased.

Real Drug Examples

Competitive inhibitors make excellent drugs because the body can flush them out, and more substrate restores normal function.

• Statins (atorvastatin, simvastatin) competitively inhibit HMG-CoA reductase, the rate-limiting enzyme of cholesterol synthesis.
• ACE inhibitors (lisinopril, enalapril) competitively inhibit angiotensin-converting enzyme, lowering blood pressure.
• Methotrexate is a folate analog that competitively inhibits dihydrofolate reductase, used in cancer chemotherapy and autoimmune disease.
• Ethanol is given as a treatment for methanol poisoning because it competes with methanol for alcohol dehydrogenase, slowing the production of toxic formaldehyde.

Not every inhibitor plays by the rules of competition. Some bind sites other than the active site and distort the enzyme. Some only bind after the substrate has already arrived. These inhibitors produce distinctly different kinetic signatures, and the MCAT will test whether you can tell them apart.

Noncompetitive Inhibition

A noncompetitive inhibitor binds at a site other than the active site (an allosteric site) and bends the enzyme into an inactive shape. It can bind the free enzyme (E) or the enzyme-substrate complex (ES) with equal affinity. Adding more substrate does NOT help - the substrate can still slip into the active site, but the catalytic step is broken because the enzyme is distorted.

Kinetic Effect

On Lineweaver-Burk, noncompetitive inhibition shifts lines up (higher y-intercept, because 1/Vmax is larger) but the x-intercept stays the same (Km unchanged). The two lines cross on the x-axis.

Uncompetitive Inhibition

An uncompetitive inhibitor binds ONLY the enzyme-substrate complex (ES), not the free enzyme. The inhibitor needs the substrate to be in place first - it binds a shape that only exists after substrate binding triggers a conformational change.

The result is counterintuitive: both Vmax AND Km decrease.

• Vmax decreases because some ES complexes are trapped and cannot release product.
• Km decreases because trapping ES pulls the E + S ⇌ ES equilibrium to the right (Le Chatelier), making it look as if the enzyme has higher affinity. More substrate is captured, not less.

Lineweaver-Burk Signature - Parallel Lines

Because both Vmax and Km decrease by the same factor, Km/Vmax (the slope on Lineweaver-Burk) is unchanged. The result is parallel lines on a double-reciprocal plot - different intercepts, same slope.

Real Examples

• Lithium (for bipolar disorder) uncompetitively inhibits inositol monophosphatase. Because lithium only binds when substrate is already there, its effect is stronger where the substrate is abundant - a neat clinical quirk.
• Some antibiotics targeting bacterial enzymes are uncompetitive to avoid complete shutdown of related human enzymes that lack the ES conformation the drug recognizes.

Side-by-Side Comparison

Pure noncompetitive inhibition (inhibitor binds E and ES with identical affinity) is mathematically tidy but biologically rare. Real-world “noncompetitive” inhibitors usually have unequal affinities for E vs. ES. That is mixed inhibition. It is the most common real form of allosteric inhibition.

The Big Idea

A mixed inhibitor binds both free enzyme (E) and the enzyme-substrate complex (ES), but not with the same strength. Let Ki be the dissociation constant for binding E, and Ki’ be the dissociation constant for binding ES.

• If Ki < Ki’ (inhibitor prefers the free enzyme), behavior looks competitive-ish: Km appears to rise.
• If Ki > Ki’ (inhibitor prefers the enzyme-substrate complex), behavior looks uncompetitive-ish: Km appears to fall.
• In both cases, Vmax drops because some enzyme is always in an inhibitor-bound state.

Kinetic Effect

Lineweaver-Burk Decision Tree

When you see an unknown inhibitor on a double-reciprocal plot, use this decision tree:

1. Do both lines share the y-intercept? Yes → competitive. No → go to step 2.
2. Do both lines share the x-intercept? Yes → noncompetitive. No → go to step 3.
3. Are the lines parallel? Yes → uncompetitive. No → mixed.

Why This Category Exists

Mixed inhibition is the honest description of what most allosteric regulators actually do. The MCAT used to lump everything non-competitive into “noncompetitive.” Modern biochem courses and the AAMC outline now distinguish mixed from pure noncompetitive. You should recognize both.

Some enzymes do not follow a simple Michaelis-Menten curve. Their velocity-vs-substrate plot is not a hyperbola but an S-shape (sigmoid). These enzymes are allosteric - they have multiple subunits and multiple binding sites that talk to each other. The conversation between subunits produces cooperativity, which is how your cells do precise, switch-like regulation of critical metabolic steps.

What “Allosteric” Means

Allos (other) + steric (place) = “binds at another place.” An allosteric site is any site on an enzyme other than the active site where a regulator can bind. Binding there triggers a conformational change that ripples through the protein, changing activity at the distant active site.

• Allosteric activators stabilize the high-activity shape (R state, “relaxed”).
• Allosteric inhibitors stabilize the low-activity shape (T state, “tense”).

Cooperativity and Sigmoidal Kinetics

Most allosteric enzymes have multiple substrate-binding sites. When one subunit binds substrate, it changes shape - and nudges the other subunits into a higher-affinity shape. The second substrate binds more easily, the third even more easily, and so on. That is positive cooperativity.

Plotting velocity vs. [S] for a cooperative enzyme gives a sigmoidal curve instead of a hyperbola. At low [S], the enzyme is sluggish. Once a critical [S] is reached, activity ramps up sharply. Past that threshold, the enzyme is essentially maxed out. Sigmoidal kinetics turn an enzyme into a switch.

• Positive cooperativity: binding one substrate makes subsequent binding easier. Sigmoidal curve. Classic example: hemoglobin binding oxygen.
• Negative cooperativity: binding one substrate makes subsequent binding harder. Less common but real (insulin receptor kinase).

Quantifying Cooperativity: The Hill Coefficient

Cooperativity is not just qualitative. You can put a number on it. The Hill coefficient (n or nH) is a measure of how strongly the subunits “talk” to each other.

You do not need to calculate Hill coefficients on the MCAT, but you should recognize a number like “n = 2.8” as “this protein shows strong positive cooperativity.” A passage that gives you a Hill plot or Hill value is testing whether you know which direction the cooperativity runs.

T State vs. R State

Two conformations interconvert:

• T state (tense) - low affinity, low activity. Promoted by allosteric inhibitors.
• R state (relaxed) - high affinity, high activity. Promoted by allosteric activators and by substrate itself.

Substrate binding pulls the equilibrium toward R. Inhibitors lock the enzyme in T. Activators lock it in R. The sigmoidal curve emerges from this T-to-R transition, which happens in a concerted all-or-nothing fashion in some models (MWC / concerted model) or one subunit at a time (KNF / sequential model). The MCAT does not require naming these models, but the concept of shifting between two states is essential.

Feedback Inhibition

Most metabolic pathways end in a product that allosterically inhibits the first committed step of its own pathway. This is feedback inhibition, and it is the main way cells avoid overproducing things they already have plenty of.

Canonical MCAT examples:

• ATP is an allosteric inhibitor of phosphofructokinase-1 (PFK-1), the rate-limiting enzyme of glycolysis. When the cell has enough energy (high ATP), glycolysis slows.
• AMP is an allosteric activator of PFK-1. Low energy (high AMP) accelerates glycolysis.
• Citrate is an allosteric inhibitor of PFK-1. A full TCA cycle signals no need for more fuel.
• CTP feedback-inhibits aspartate transcarbamoylase (ATCase), the classic textbook allosteric enzyme of pyrimidine synthesis.

Hemoglobin Is the MCAT’s Favorite Allosteric Protein

Hemoglobin is not an enzyme, but it is the textbook cooperative protein. Four subunits, each binding one O2. Binding the first O2 is hard (T state). Once bound, the subunit shifts to R, pulling the others with it. The second, third, and fourth O2 molecules bind much more easily. The result is a sigmoidal O2 saturation curve that allows hemoglobin to load O2 efficiently in the lungs (high O2) and unload it in tissues (low O2).

Negative regulators that stabilize T (2,3-BPG, H+, CO2) cause hemoglobin to release more O2 in tissues - the Bohr effect. Know this example cold; it shows up constantly. Full coverage of hemoglobin is in Chapter 3.

Cells switch enzymes on and off by covalently attaching small chemical groups to specific residues. This is the fastest way to tune activity without synthesizing or degrading the protein, which makes covalent modification the workhorse of cellular regulation.

Phosphorylation - The Master Switch

The most common and MCAT-tested modification is phosphorylation. A kinase transfers a phosphate from ATP onto a hydroxyl-containing residue (Ser, Thr, or Tyr). A phosphatase removes the phosphate by hydrolysis.

$\text{Enzyme-OH} + \text{ATP} \xrightarrow{\text{kinase}} \text{Enzyme-O-PO}_3^{2-} + \text{ADP}$

Phosphate adds two negative charges and a bulky group. That changes local shape and often switches activity - sometimes activating, sometimes inhibiting, depending on the enzyme.

Examples of Phosphorylation Switches

Notice the pattern: in the fasted/stressed state, phosphorylation activates enzymes that release glucose and fat, and inactivates enzymes that store them. Insulin, the “fed” hormone, reverses each of these by activating phosphatases.

Glycosylation

Sugars (usually carbohydrate chains) are attached to specific residues - Asn (N-linked) or Ser/Thr (O-linked). Glycosylation happens in the ER and Golgi and is essential for:

• Directing proteins to the correct destination (lysosomal enzymes carry mannose-6-phosphate tags).
• Stabilizing secreted proteins in the harsh extracellular environment.
• Cell-surface recognition (blood type antigens are carbohydrates on red blood cells).

Ubiquitination - The Destruction Signal

Ubiquitin is a small protein that gets covalently attached to lysine residues of target proteins. A single ubiquitin can regulate location or activity. A chain of ubiquitins (polyubiquitination) tags the protein for destruction by the 26S proteasome.

Acetylation and Methylation

Two more modifications worth recognizing, especially in the context of gene regulation:

• Acetylation of lysine residues by HATs (histone acetyltransferases) neutralizes their positive charge. In histones, this loosens the DNA-histone interaction and activates transcription. HDACs (histone deacetylases) reverse the process.
• Methylation of lysine or arginine (and of DNA cytosines) can activate or repress transcription depending on the residue and context. Methylation of CpG islands in DNA typically silences gene expression.

Some enzymes are dangerous if they are active in the wrong place at the wrong time. The cell synthesizes them in an inactive precursor form called a zymogen (or proenzyme) and activates them only when and where needed, usually by cleaving off a peptide. Once cut, the zymogen cannot go back to being inactive - activation is irreversible, which is why the cell is so careful about where it happens.

Digestive Zymogens

Pancreatic digestive enzymes are the textbook example. If pepsin, trypsin, chymotrypsin, or elastase were active in the pancreas, they would digest the pancreas itself (a real disease: acute pancreatitis). So the pancreas synthesizes them as zymogens and releases them into the small intestine for activation.

Notice the key node: trypsin activates all the others. Enteropeptidase (also called enterokinase) in the duodenal brush border cleaves trypsinogen to trypsin; trypsin then activates itself and every other pancreatic zymogen. This is called a proteolytic cascade.

The Blood Clotting Cascade

Clotting is a proteolytic cascade of zymogen activations. Each factor is a zymogen; when cut, it becomes an active protease that cuts the next factor in line. This amplifies the signal - a tiny initial trigger produces a large, localized clot within seconds.

• Intrinsic pathway: triggered by contact with damaged surface (Factor XII → XI → IX → X).
• Extrinsic pathway: triggered by tissue factor (VII → X).
• Both pathways converge at Factor X → Xa, which activates prothrombin (II) to thrombin (IIa). Thrombin converts fibrinogen to fibrin, forming the clot.

Warfarin blocks vitamin K recycling, which is needed to gamma-carboxylate clotting factors II, VII, IX, and X - so warfarin indirectly inhibits clotting by producing non-functional zymogens.

Apoptosis - Caspase Cascade

Programmed cell death uses a similar cascade of zymogen activations. Caspases (cysteine-aspartate proteases) are synthesized as procaspases. Initiator caspases (e.g., caspase-8, -9) cleave and activate executioner caspases (caspase-3, -6, -7), which then dismantle the cell in an orderly way. Because the cascade is irreversible, the decision to die is committed once the first executioner caspase is activated.

Regulatory Enzymes in a Pathway

Beyond zymogens, most metabolic pathways have one or two “regulatory enzymes” that control flux. These are usually:

• The rate-limiting enzyme (slowest step of the pathway at normal conditions).
• An enzyme catalyzing an irreversible step, so regulation is meaningful.
• Subject to multiple regulatory inputs - allosteric effectors, covalent modification, hormonal control.

Examples you should recognize:

• PFK-1 regulates glycolysis.
• HMG-CoA reductase regulates cholesterol synthesis (target of statins).
• Acetyl-CoA carboxylase regulates fatty acid synthesis.
• Glycogen phosphorylase regulates glycogen breakdown.

These are expanded in the metabolism chapters. For now, just know that the cell concentrates regulation at a few key control points rather than controlling every step of every pathway.